There are only two possible reasons for the substantial share price decrease since the ASX query to Lynas some weeks back after the half year account announcement: (1) the market knows more than we do (possibly because of an involvement of a financial institution in a loan negotiation of capital raising + that particular financial institution is making use of this exclusive information); or (2) somebody is taking money into their hands to drive the share price down for a particular reason (shorting, a takeover bid, etc.).
If (1) is the case and Lynas is aware, I assume that Lynas would have to announce this to the market. Hence, they would be walking on very thin ice. As a result, I assume that (2) is more realistic and we do not know the reason for that. However, it would not affect LT holders looking to Lynas fundamentals unless there is a takeover with a squeeze-out at current prices. That is the absolute worst case scenario.
- Forums
- ASX - By Stock
- LYC
- lynas road to profitability and share price.
lynas road to profitability and share price., page-9
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.63 |
Change
-0.120(1.55%) |
Mkt cap ! $7.169B |
Open | High | Low | Value | Volume |
$7.64 | $7.69 | $7.61 | $3.174M | 415.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 3922 | $7.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.63 | 3891 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 6985 | 7.640 |
23 | 17088 | 7.630 |
15 | 19287 | 7.620 |
12 | 16340 | 7.610 |
15 | 55344 | 7.600 |
Price($) | Vol. | No. |
---|---|---|
7.650 | 4283 | 24 |
7.660 | 10904 | 27 |
7.670 | 7562 | 16 |
7.680 | 17590 | 16 |
7.690 | 10225 | 10 |
Last trade - 12.05pm 13/11/2024 (20 minute delay) ? |
Featured News
LYC (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online